MEDICINOVA, INC. Other Nonoperating Income (Expense)
MEDICINOVA, INC. (MNOV) reported Other Nonoperating Income (Expense) of -$4.88 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-13
- MEDICINOVA, INC. other nonoperating income (expense) for the quarter ending 2026-06-30 was -$4.88K, a 612.71% decline year-over-year.
- MEDICINOVA, INC. other nonoperating income (expense) for the quarter ending 2026-03-31 was -$3.42K, a 249.89% decline year-over-year.
- MEDICINOVA, INC. other nonoperating income (expense) for the quarter ending 2025-12-31 was -$5.76K.
- MEDICINOVA, INC. other nonoperating income (expense) for the quarter ending 2025-09-30 was -$10.22K, a 212.34% decline year-over-year.
- MEDICINOVA, INC. other nonoperating income (expense) for fiscal 2025 was -$12.75K.
- MEDICINOVA, INC. other nonoperating income (expense) for fiscal 2024 was -$39.48K.
- MEDICINOVA, INC. other nonoperating income (expense) for fiscal 2023 was -$502.87K.
- MEDICINOVA, INC. other nonoperating income (expense) for fiscal 2022 was -$247.28K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 6 month as first filed | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 9 month as first filed | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$4.88K 10-Q · filed 2026-08-13 | -$8.30K 10-Q · filed 2026-08-13 | -$14.06K derived: sum of 3 quarters · filed 2026-08-13 | -$24.28K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2026-03-31 | -$3.42K 10-Q · filed 2026-05-14 | -$9.18K derived: sum of 2 quarters · filed 2026-05-14 | -$19.40K derived: sum of 3 quarters · filed 2026-05-14 | -$18.45K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-12-31 | -$5.76K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$15.98K derived: sum of 2 quarters · filed 2026-03-10 | -$15.03K derived: sum of 3 quarters · filed 2026-08-13 | -$12.75K 10-K · filed 2026-03-10 | |||
| 2025-09-30 | -$10.22K 10-Q · filed 2025-11-12 | -$9.27K derived: sum of 2 quarters · filed 2026-08-13 | -$6.99K 10-Q · filed 2025-11-12 | -$22.49K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-06-30 | $952.00 10-Q · filed 2026-08-13 | $3.23K 10-Q · filed 2026-08-13 | -$12.27K derived: sum of 3 quarters · filed 2026-08-13 | -$3.16K derived: sum of 4 quarters · filed 2026-08-13 | |||
| 2025-03-31 | $2.28K 10-Q · filed 2026-05-14 | -$13.22K derived: sum of 2 quarters · filed 2026-05-14 | -$4.12K derived: sum of 3 quarters · filed 2026-05-14 | -$21.17K derived: sum of 4 quarters · filed 2026-05-14 | |||
| 2024-12-31 | -$15.50K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | -$6.39K derived: sum of 2 quarters · filed 2026-03-10 | -$23.45K derived: sum of 3 quarters · filed 2026-03-10 | -$39.48K 10-K · filed 2026-03-10 | |||
| 2024-09-30 | $9.10K 10-Q · filed 2025-11-12 | -$7.95K derived: sum of 2 quarters · filed 2025-11-12 | -$23.99K 10-Q · filed 2025-11-12 | -$26.19K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | -$17.05K 10-Q · filed 2025-08-14 | -$33.09K 10-Q · filed 2025-08-14 | -$35.29K derived: sum of 3 quarters · filed 2025-08-14 | -$49.44K derived: sum of 4 quarters · filed 2025-08-14 | |||
| 2024-03-31 | -$16.04K 10-Q · filed 2025-05-13 | -$18.23K derived: sum of 2 quarters · filed 2025-05-13 | -$32.39K derived: sum of 3 quarters · filed 2025-05-13 | -$55.60K derived: sum of 4 quarters · filed 2025-05-13 | |||
| 2023-12-31 | -$2.20K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-19 | -$16.35K derived: sum of 2 quarters · filed 2025-02-19 | -$39.56K derived: sum of 3 quarters · filed 2025-02-19 | -$502.87K 10-K · filed 2025-02-19 | |||
| 2023-09-30 | -$14.15K 10-Q · filed 2024-11-13 | -$37.36K derived: sum of 2 quarters · filed 2024-11-13 | -$500.67K 10-Q · filed 2024-11-13 | -$695.40K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | -$23.21K 10-Q · filed 2024-08-08 | -$486.52K 10-Q · filed 2024-08-08 | -$681.25K derived: sum of 3 quarters · filed 2024-08-08 | -$689.72K derived: sum of 4 quarters · filed 2024-08-08 | |||
| 2023-03-31 | -$463.31K 10-Q · filed 2024-05-09 | -$658.04K derived: sum of 2 quarters · filed 2024-05-09 | -$666.51K derived: sum of 3 quarters · filed 2024-05-09 | -$696.85K derived: sum of 4 quarters · filed 2024-05-09 | |||
| 2022-12-31 | -$194.73K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15 | -$203.20K derived: sum of 2 quarters · filed 2024-02-15 | -$233.54K derived: sum of 3 quarters · filed 2024-02-15 | -$247.28K 10-K · filed 2024-02-15 | |||
| 2022-09-30 | -$8.47K 10-Q · filed 2023-11-09 | -$38.81K derived: sum of 2 quarters · filed 2023-11-09 | -$52.55K 10-Q · filed 2023-11-09 | -$66.77K derived: sum of 4 quarters · filed 2023-11-09 | |||
| 2022-06-30 | -$30.34K 10-Q · filed 2023-08-09 | -$44.08K 10-Q · filed 2023-08-09 | -$58.30K derived: sum of 3 quarters · filed 2023-08-09 | -$71.68K derived: sum of 4 quarters · filed 2023-08-09 | |||
| 2022-03-31 | -$13.74K 10-Q · filed 2023-05-11 | -$27.96K derived: sum of 2 quarters · filed 2023-05-11 | -$41.34K derived: sum of 3 quarters · filed 2023-05-11 | -$50.30K derived: sum of 4 quarters · filed 2023-05-11 | |||
| 2021-12-31 | -$14.21K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-28 | -$27.59K derived: sum of 2 quarters · filed 2023-03-28 | -$36.56K derived: sum of 3 quarters · filed 2023-03-28 | -$59.50K 10-K/A · filed 2023-03-28 | |||
| 2021-09-30 | -$13.38K 10-Q · filed 2022-11-10 | -$22.35K derived: sum of 2 quarters · filed 2022-11-10 | -$45.28K 10-Q · filed 2022-11-10 | -$55.79K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$8.97K 10-Q · filed 2022-08-11 | -$31.90K 10-Q · filed 2022-08-11 | -$42.41K derived: sum of 3 quarters · filed 2022-08-11 | -$53.41K derived: sum of 4 quarters · filed 2022-08-11 | |||
| 2021-03-31 | -$22.94K 10-Q · filed 2022-05-12 | -$33.44K derived: sum of 2 quarters · filed 2022-05-12 | -$44.45K derived: sum of 3 quarters · filed 2022-05-12 | -$49.00K derived: sum of 4 quarters · filed 2022-05-12 | |||
| 2020-12-31 | -$10.50K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$21.51K derived: sum of 2 quarters · filed 2022-02-16 | -$26.06K derived: sum of 3 quarters · filed 2022-02-16 | -$38.40K 10-K · filed 2022-02-16 | |||
| 2020-09-30 | -$11.01K 10-Q · filed 2021-11-12 | -$15.56K derived: sum of 2 quarters · filed 2021-11-12 | -$27.90K 10-Q · filed 2021-11-12 | -$22.98K derived: sum of 4 quarters · filed 2021-11-12 | |||
| 2020-06-30 | -$4.55K 10-Q · filed 2021-08-12 | -$16.89K 10-Q · filed 2021-08-12 | -$11.97K derived: sum of 3 quarters · filed 2021-08-12 | -$33.55K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | -$12.34K 10-Q · filed 2021-05-13 | -$7.42K derived: sum of 2 quarters · filed 2021-05-13 | -$29.00K derived: sum of 3 quarters · filed 2021-05-13 | -$36.43K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $4.92K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-19 | -$16.66K derived: sum of 2 quarters · filed 2021-02-19 | -$24.09K derived: sum of 3 quarters · filed 2021-02-19 | -$46.16K 10-K · filed 2021-02-19 | |||
| 2019-09-30 | -$21.58K 10-Q · filed 2020-10-26 | -$29.01K derived: sum of 2 quarters · filed 2020-10-26 | -$51.09K 10-Q · filed 2020-10-26 | -$51.40K derived: sum of 4 quarters · filed 2020-10-26 | |||
| 2019-06-30 | -$7.43K 10-Q · filed 2020-07-28 | -$29.50K 10-Q · filed 2020-07-28 | -$29.82K derived: sum of 3 quarters · filed 2020-07-28 | -$50.50K derived: sum of 4 quarters · filed 2020-07-28 | |||
| 2019-03-31 | -$22.08K 10-Q · filed 2020-04-23 | -$22.39K derived: sum of 2 quarters · filed 2020-04-23 | -$43.07K derived: sum of 3 quarters · filed 2020-04-23 | -$37.16K derived: sum of 4 quarters · filed 2020-04-23 | |||
| 2018-12-31 | -$310.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$20.99K derived: sum of 2 quarters · filed 2020-02-13 | -$15.08K derived: sum of 3 quarters · filed 2020-02-13 | -$22.89K 10-K · filed 2020-02-13 | |||
| 2018-09-30 | -$20.68K 10-Q · filed 2019-10-24 | -$19.02K 10-Q · filed 2018-10-25 | -$14.77K derived: sum of 2 quarters · filed 2019-10-24 | -$22.58K 10-Q · filed 2019-10-24 | -$19.01K 10-Q · filed 2018-10-25 | -$34.40K derived: sum of 4 quarters · filed 2019-10-24 | |
| 2018-06-30 | $5.91K 10-Q · filed 2019-07-25 | $7.82K 10-Q · filed 2018-07-23 | -$1.90K 10-Q · filed 2019-07-25 | $4.00 10-Q · filed 2018-07-23 | -$13.72K derived: sum of 3 quarters · filed 2019-07-25 | -$17.03K derived: sum of 4 quarters · filed 2019-07-25 | |
| 2018-03-31 | -$7.82K 10-Q · filed 2019-04-25 | -$19.63K derived: sum of 2 quarters · filed 2019-04-25 | -$22.94K derived: sum of 3 quarters · filed 2019-04-25 | -$28.97K derived: sum of 4 quarters · filed 2019-04-25 | |||
| 2017-12-31 | -$11.82K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-13 | -$15.13K derived: sum of 2 quarters · filed 2019-02-13 | -$21.15K derived: sum of 3 quarters · filed 2019-02-13 | -$25.60K 10-K · filed 2019-02-13 | |||
| 2017-09-30 | -$3.31K 10-Q · filed 2018-10-25 | -$9.34K derived: sum of 2 quarters · filed 2018-10-25 | -$13.78K 10-Q · filed 2018-10-25 | ||||
| 2017-06-30 | -$6.03K 10-Q · filed 2018-07-23 | -$10.47K 10-Q · filed 2018-07-23 | |||||
| 2016-12-31 | -$47.04K 10-K · filed 2019-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |